Literature DB >> 34736135

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe.

Jiao-Cen Guo1, Li Yang1, Qing-Yun Ma1, Ya-Zhe Ge2, Fan-Dong Kong3, Li-Man Zhou3, Qing-Yi Xie1, Zhi-Fang Yu4, Hao-Fu Dai5, You-Xing Zhao6.   

Abstract

Macrofungi Ganoderma is a valuable medicinal fungus resource for human health and longevity in China. In this study, ten undescribed compounds including seven lostane-type triterpenoids, ganodaustralic acids A ∼ G (1-7), one pair of meroterpenoid enantiomers, (-)-6'-O-ethyllingzhiol (8) and (+)-6'-O-ethyllingzhiol (9), and one polyhydroxylated sterol, 3-O-acetyl-fomentarol C (10), together with eight known compounds (11-18), were isolated from the fruiting bodies of Ganoderma australe. The structures of the new compounds were elucidated by extensive spectroscopic analysis as well as NMR and electronic circular dichroism (ECD) calculations. Compounds 4, 8, 9, and 12 showed significant α-glucosidase inhibitory activities with IC50 values in the range of 4.1-11.7 μM, which were superior to that of positive control acarbose (213 μM). Only compound 7 exhibited weak cytotoxicity against SGC-7901 cells.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Ganoderma australe; Meroterpenoids; Triterpenoids; α-glucosidase inhibitory activity

Mesh:

Substances:

Year:  2021        PMID: 34736135     DOI: 10.1016/j.bioorg.2021.105448

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  [20(22)E]-Lanostane Triterpenes from the Fungus Ganoderma australe.

Authors:  Lin Zhou; Li-Li Guo; Masahiko Isaka; Zheng-Hui Li; He-Ping Chen
Journal:  J Fungi (Basel)       Date:  2022-05-12

2.  Tetra-, penta-, and hexa-nor-lanostane triterpenes from the medicinal fungus Ganoderma australe.

Authors:  Lin Zhou; Subiy Akbar; Meng-Xi Wang; He-Ping Chen; Ji-Kai Liu
Journal:  Nat Prod Bioprospect       Date:  2022-08-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.